Tau local structure shields an amyloid-forming motif and controls aggregation propensity

Autor: Dailu Chen, Da Nae R. Woodard, Levent Sari, Omar M. Kashmer, Lukasz A. Joachimiak, Valerie A. Perez, Kenneth W. Drombosky, Marc I. Diamond, Milo M. Lin, Bryan D. Ryder, Zhiqiang Hou
Rok vydání: 2019
Předmět:
0301 basic medicine
Prions
Science
In silico
Amino Acid Motifs
Tau protein
Mutation
Missense

General Physics and Astronomy
tau Proteins
Peptide
02 engineering and technology
Protein aggregation
Protein Aggregation
Pathological

Mass Spectrometry
Article
General Biochemistry
Genetics and Molecular Biology

Quantitative Biology::Cell Behavior
03 medical and health sciences
Microscopy
Electron
Transmission

mental disorders
Humans
Missense mutation
Computer Simulation
lcsh:Science
Gene
chemistry.chemical_classification
Quantitative Biology::Biomolecules
Intrinsically disordered proteins
Multidisciplinary
biology
Chemistry
HEK 293 cells
Alternative splicing
General Chemistry
021001 nanoscience & nanotechnology
Recombinant Proteins
Cell biology
HEK293 Cells
030104 developmental biology
Tauopathies
biology.protein
lcsh:Q
0210 nano-technology
Zdroj: Nature Communications
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
ISSN: 2041-1723
DOI: 10.1038/s41467-019-10355-1
Popis: Tauopathies are neurodegenerative diseases characterized by intracellular amyloid deposits of tau protein. Missense mutations in the tau gene (MAPT) correlate with aggregation propensity and cause dominantly inherited tauopathies, but their biophysical mechanism driving amyloid formation is poorly understood. Many disease-associated mutations localize within tau’s repeat domain at inter-repeat interfaces proximal to amyloidogenic sequences, such as 306VQIVYK311. We use cross-linking mass spectrometry, recombinant protein and synthetic peptide systems, in silico modeling, and cell models to conclude that the aggregation-prone 306VQIVYK311 motif forms metastable compact structures with its upstream sequence that modulates aggregation propensity. We report that disease-associated mutations, isomerization of a critical proline, or alternative splicing are all sufficient to destabilize this local structure and trigger spontaneous aggregation. These findings provide a biophysical framework to explain the basis of early conformational changes that may underlie genetic and sporadic tau pathogenesis.
The biophysical mechanisms of how disease-associated tau mutations drive amyloid formation are not well understood. Here the authors use biophysical approaches, cell models and MD simulations and find that the intrinsically disordered repeat domain of tau encodes a metastable local structure and perturbations through mutations and proline isomerization cause an aggregation phenotype in vitro and in cells.
Databáze: OpenAIRE